Chemotherapy types and mechanisms
Pro Research Analysisby 
Searched over 200M research papers
Chemotherapy Types: Cytotoxic Agents and Targeted Therapies
Chemotherapy is a primary treatment for many cancers and includes several main types of drugs, each with distinct mechanisms. The most common classes are antimetabolites, alkylating agents, mitotic spindle inhibitors, and topoisomerase inhibitors. These drugs generally work by interfering with DNA synthesis, replication, or cell division, leading to the direct killing of rapidly dividing tumor cells 26. In addition to these traditional cytotoxic agents, newer targeted therapies and immunotherapies are increasingly used, aiming at specific molecular pathways or immune responses involved in cancer progression .
Mechanisms of Action: Direct Tumor Cell Killing and Immune System Activation
Historically, chemotherapy was believed to act solely by directly killing cancer cells through DNA damage or disruption of cell division. However, research now shows that chemotherapy also has important effects on the immune system. Some chemotherapeutic agents can make dying tumor cells more visible to the immune system, stimulate both innate and adaptive immune responses, and even induce a type of cell death that triggers immune activation against the tumor 13. These immune-based mechanisms can enhance the overall effectiveness of chemotherapy and are important for designing combination treatments with immunotherapy 13.
Chemotherapy Resistance: Molecular and Cellular Mechanisms
A major challenge in chemotherapy is the development of resistance, which can be intrinsic (present before treatment) or acquired (develops during treatment). Resistance mechanisms include:
- Increased drug efflux (pumping drugs out of cells)
- Enhanced DNA repair
- Inhibition of apoptosis (programmed cell death)
- Altered drug metabolism
- Changes in drug targets
- Epigenetic modifications
- Presence of cancer stem cells
- Influence of the tumor microenvironment 2457+3 MORE
These mechanisms can act alone or together, making it difficult to treat resistant cancers. For example, drug transporters like P-glycoprotein can reduce drug accumulation in cancer cells, while enhanced DNA repair allows cells to survive chemotherapy-induced damage 279. The tumor microenvironment, including immune cells and signaling molecules, also plays a key role in determining how tumors respond to chemotherapy 310.
Overcoming Chemotherapy Resistance: Strategies and Future Directions
To address resistance, researchers are developing combination therapies that target multiple pathways, using drugs that inhibit resistance mechanisms, and exploring novel drug delivery systems. Combining chemotherapy with immunotherapy or targeted agents can improve outcomes by attacking cancer on several fronts 6710. Identifying biomarkers that predict response to chemotherapy and understanding the specific resistance mechanisms in different cancer types are also important for personalizing treatment and improving success rates 5610.
Conclusion
Chemotherapy includes a range of drug types that work by directly killing cancer cells and by activating the immune system. Resistance to chemotherapy is a complex problem involving multiple molecular and cellular mechanisms. Ongoing research aims to overcome resistance through combination therapies, targeted treatments, and personalized approaches, offering hope for more effective cancer care in the future 267.
Sources and full results
Most relevant research papers on this topic